116 related articles for article (PubMed ID: 6300016)
1. Kinetics and significance of the activity of the Sabath and Abrahams' beta-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodin.
Livermore DM
J Antimicrob Chemother; 1983 Feb; 11(2):169-79. PubMed ID: 6300016
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
[TBL] [Abstract][Full Text] [Related]
3. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
Then RL; Angehrn P
Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.
Jacobs JY; Livermore DM; Davy KW
J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226
[TBL] [Abstract][Full Text] [Related]
5. Permeability to cefsulodin of the outer membrane of Pseudomonas aeruginosa and discrimination between beta-lactamase-mediated trapping and hydrolysis as mechanisms of resistance.
Hewinson RG; Cartwright SJ; Slack MP; Whipp RD; Woodward MJ; Nichols WW
Eur J Biochem; 1989 Feb; 179(3):667-75. PubMed ID: 2493375
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
Livermore DM; Yang YJ
J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
[No Abstract] [Full Text] [Related]
8. Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.
Livermore DM; Williams JD; Davy KW
Chemioterapia; 1985 Feb; 4(1):28-35. PubMed ID: 3921264
[TBL] [Abstract][Full Text] [Related]
9. The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.
Fu KP; Neu HC
J Antibiot (Tokyo); 1979 Sep; 32(9):909-14. PubMed ID: 315938
[TBL] [Abstract][Full Text] [Related]
10. Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal beta-lactamase to piperacillin, ceftazidime, and cefsulodin.
Bryan LE; Kwan S; Godfrey AJ
Antimicrob Agents Chemother; 1984 Mar; 25(3):382-4. PubMed ID: 6426382
[TBL] [Abstract][Full Text] [Related]
11. [Beta-lactamase induction in Pseudomonas aeruginosa by cefpiramide and 3 other antipyocyanic cephalosporins].
Drigues P; Lanau C; Combes T; Roche G; Salhi A
Pathol Biol (Paris); 1986 May; 34(5):419-23. PubMed ID: 3095775
[TBL] [Abstract][Full Text] [Related]
12. Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolates.
Livermore DM; Jones CS
Antimicrob Agents Chemother; 1986 Jan; 29(1):99-103. PubMed ID: 3089139
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporin.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1983 Sep; 24(3):375-82. PubMed ID: 6605719
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
Satake S; Hiraoka M; Mitsuhashi S
Antimicrob Agents Chemother; 1989 Mar; 33(3):398-9. PubMed ID: 2658787
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases.
King A; Shannon K; Phillips I
Antimicrob Agents Chemother; 1980 Feb; 17(2):165-9. PubMed ID: 6770753
[TBL] [Abstract][Full Text] [Related]
16. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ
J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
Labia R; Morand A; Ben Yaghlane H
Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
[TBL] [Abstract][Full Text] [Related]
19. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
Hiraoka M; Inoue M; Mitsuhashi S
Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
[TBL] [Abstract][Full Text] [Related]
20. Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M
Antimicrob Agents Chemother; 1979 Dec; 16(6):757-60. PubMed ID: 316989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
